Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ZVRA is expected to report earnings to rise 2.36% to 14 cents per share on November 11
Q3'26
Est.
$0.14
Q2'26
Beat
by $0.03
Q1'26
Beat
by $0.53
Q4'25
Beat
by $0.14
Q3'25
Beat
by $0.02
The last earnings report on August 05 showed earnings per share of 14 cents, beating the estimate of 10 cents. With 275.04K shares outstanding, the current market capitalization sits at 663.91M.